Neotrace-4
FDA Approves Dotarem, a New MRI Agent »
"The U.S. Food and Drug Administration today approved Dotarem (gadoterate meglumine) for use in magnetic resonance imaging (MRI) of the brain, spine and associated tissues of patients ages 2 years and older.
Dotarem is a gadolinium-based"...
Neotrace-4
Neotrace-4 Side Effects Center
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
Neotrace-4 FDA Prescribing Information: Side Effects
(Adverse Reactions)
SIDE EFFECTS
The amounts of zinc, copper, chromium and manganese in Neotrace®-4 are very small and toxicity symptoms due to these trace elements at suggested dosage levels are considered unlikely to occur.
Drug Abuse and Dependence
None known.
Read the entire FDA prescribing information for Neotrace-4 (Metal-4 Combination (for Neonates)) »
Additional Neotrace-4 Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Women's Health
Find out what women really need.
Updated & New
